Automated deep research was attempted on 2026-07-18. Falcon failed with HTTP 402 and the Perplexity-lite fallback failed with HTTP 401. This manually curated synthesis records the literature conclusions used for the review.
ARSI is a SUMF1-activated class I sulfatase. The 2009 human ARPE-19 study showed neutral-pH activity against artificial 4-methylumbelliferyl sulfate only when ARSI and SUMF1 were coexpressed, and the C93S mutant lacked activity PMID:19262745 PMID:19262745.
The 2026 Matrix Biology paper supplies the decisive natural-substrate result: human ARSI overexpression lowered cellular C4S, Arsi knockout increased C4S, and purified SUMF1-activated human ARSI desulfated GalNAc4S but not GalNAc6S. The cached abstract states that PMID:41916471. This supports the specific GO term GO:0003943 rather than relying only on broad arylsulfatase or sulfuric-ester-hydrolase terms.
The 2009 study observed FLAG-tagged ARSI in ER and medium PMID:19262745. The study used transient overexpression and itself discussed instability, degradation, and ER retention, so these observations do not establish that extracellular space is the principal native compartment.
The later study localized human ARSI with lysosomal/endosomal markers and found altered lysosome abundance and size after Arsi loss in chondrocytes. Its abstract reports PMID:41916471. Acidic pH preference for GalNAc4S further coheres with lysosomal function. Lysosome is thus the core functional location, while ER lumen is a biosynthetic/formylglycine-maturation location and extracellular region remains non-core overexpression evidence.
ARSI abundance rises during chondrocyte maturation in multiple vertebrate models. Rat chondrocyte Arsi knockout increased maturation-marker expression, including after FGF18 induction PMID:41916471. This supports negative regulation of chondrocyte differentiation, but because the perturbation evidence is from rat cells the human annotation should use ISS.
The KRT40 interaction comes from a systematic binary interactome map PMID:25416956. It has no ARSI-specific physiological validation and does not justify generic protein binding as an informative core function.
The 2014 exome study included ARSI among putative HSP candidates but its abstract frames the output as candidate discovery PMID:24482476. Without accessible ARSI-specific segregation and functional details, the SPG66 association is noted as unresolved and is not converted to GO biology.
ARSI is best modeled as a lysosomal, SUMF1-dependent N-acetylgalactosamine-4-sulfatase that removes terminal 4-sulfate from chondroitin/dermatan sulfate chains and restrains chondrocyte maturation in experimental vertebrate cartilage systems. The older extracellular neutral-pH model was informative but is no longer the strongest account of its core physiological compartment and substrate.
The physiological human proteoglycan substrates and the significance of a possible extracellular pool remain unresolved.